Pacira BioSciences, Inc. PCRX Business Segments — Total other (expense) income, net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s business segments — total other (expense) income, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s business segments — total other (expense) income, net?
- Pacira BioSciences, Inc. (PCRX) reported business segments — total other (expense) income, net of -$1.9M in Q1 2026.
- How has Pacira BioSciences, Inc.'s business segments — total other (expense) income, net changed year-over-year?
- Pacira BioSciences, Inc.'s business segments — total other (expense) income, net decreased by 128.4% year-over-year, from $6.72M to -$1.9M.
- What is the long-term trend for Pacira BioSciences, Inc.'s business segments — total other (expense) income, net?
- Over 2 years (2022 to 2024), Pacira BioSciences, Inc.'s business segments — total other (expense) income, net has grown at a -53.1% compound annual growth rate (CAGR), from -$46.72M to $10.27M.
- What does business segments — total other (expense) income, net mean?
- This metric captures the net impact of non-operating financial activities, such as interest income, interest expense, and gains or losses on debt extinguishment. It reflects the segment's financial management outside of core operational revenue generation. A positive value indicates net non-operating income, while a negative value indicates a net expense.